Togo vs Vietnam: Antiretroviral therapy coverage for PMTCT
Togo
87.0%
in 2024
Vietnam
85.0%
in 2024
Togo rank
33rd
Vietnam rank
35th
Antiretroviral therapy coverage for PMTCT over time
- Togo
- Vietnam
How they compare
Togo currently reports 87.0% against 85.0% in Vietnam, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Vietnam ahead.
Togo ranks 33rd and Vietnam ranks 35th of 84 countries.
Across the 3 decades both report, Togo averaged higher in 2 and Vietnam in 1.
Head to head by decade
| Decade | Togo | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.3% | 28.7% | 21.4% | Vietnam |
| 2010s | 83.4% | 60.4% | 23.0% | Togo |
| 2020s | 85.4% | 78.2% | 7.2% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Togo or Vietnam?
- Togo, at 87.0% against 85.0% in Vietnam as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Togo and Vietnam?
- 2.0%, with Togo ahead.
- How many years of comparable data are there for Togo and Vietnam?
- 25 years are reported by both, from 2000 to 2024.
- How do Togo and Vietnam rank globally for antiretroviral therapy coverage for pmtct?
- Togo ranks 33rd and Vietnam ranks 35th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).